On 17 February 2017, Cann Group Ltd. (ASX:CAN) (OTC:CNGGF) (FRA:CVJ) was issued Australia’s first Medicinal Cannabis Research Licence issued in accordance with the Narcotic Drugs Act 1967. Cann has established research and development and cultivation facilities in Australia and has executed collaboration agreements that will enable it to establish a leading position in plant genetics; breeding; cultivation; extraction; analysis and production techniques to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.
Australia